https://www.washingtonpost.com/health/2022/01/24/biden-administration-monoclonal-antibodies/ https://www.businessinsider.com/fda-stop-monoclonal-antibody-treatments-ineffective-against-omicron-coronavirus-report-2022-1 FDA poised to stop monoclonal antibody treatments that are ineffective against the Omicron COVID-19 variant The FDA is set to halt the COVID-19 treatments made by Eli Lilly and Re..
investor.regeneron.com/news-releases/news-release-details/phase-3-trial-shows-regen-covtm-casirivimab-imdevimab-antibody Phase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-h TARRYTOWN, N.Y. , March 23, 2021 /PRNewswire/ -- REGEN-COV also significantly shortened the duration of symptoms by 4 days All doses (8,000 mg, 2,400 ..